Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database-Reference-Cited by-同舟云学术

Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database

Published:2020-08 Issue:8 Volume:26 Page:1017-1026
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Guo Jennifer D.¹,Rajpura Jigar¹,Hlavacek Patrick²,Keshishian Allison³,Sah Janvi³,Delinger Rachel³,Mu Qiao³,Mardekian Jack²,Russ Cristina²,Okano Gary J.¹,Rosenblatt Lisa¹

Affiliation:

1. Bristol Myers Squibb, Lawrenceville, New Jersey.

2. Pfizer, New York, New York.

3. SIMR, LLC, Ann Arbor, Michigan.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of the Direct Cost of Management of Venous Thromboembolism in Three Reference Hospitals in the City of Yaoundé: A Retrospective Study over a Three-Year Period;World Journal of Cardiovascular Diseases;2024

2. Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysis;Journal of Managed Care & Specialty Pharmacy;2022-11

3. Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis;Clinical Journal of the American Society of Nephrology;2022-05

4. Rare Presentation of Deep Vein Thrombosis and Submassive Pulmonary Emboli Due to Hypercoagulable State With Supratherapeutic Anticoagulation;Cureus;2021-08-19

5. Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach;Journal of Clinical Epidemiology;2021-02